131 related articles for article (PubMed ID: 25222075)
1. Influence of Comorbidity on the Risk of Death: A Single Institution Study of 1132 Women With Early-stage Uterine Cancer.
Elshaikh MA; Vance S; Kamal M; Burmeister C; Hanna RK; Rasool N; Siddiqui F
Am J Clin Oncol; 2017 Apr; 40(2):183-188. PubMed ID: 25222075
[TBL] [Abstract][Full Text] [Related]
2. Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer.
Robbins JR; Gayar OH; Zaki M; Mahan M; Buekers T; Elshaikh MA
Gynecol Oncol; 2013 Dec; 131(3):593-7. PubMed ID: 24125752
[TBL] [Abstract][Full Text] [Related]
3. Predictive Capacity of 3 Comorbidity Indices in Estimating Survival Endpoints in Women With Early-Stage Endometrial Carcinoma.
Al Feghali KA; Robbins JR; Mahan M; Burmeister C; Khan NT; Rasool N; Munkarah A; Elshaikh MA
Int J Gynecol Cancer; 2016 Oct; 26(8):1455-60. PubMed ID: 27488218
[TBL] [Abstract][Full Text] [Related]
4. Does Age-Adjusted Charlson Comorbidity Score Impact Survival Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial Cancer?
Ghanem AI; Modh A; Burmeister C; Munkarah AR; Elshaikh MA
Gynecol Obstet Invest; 2018; 83(3):290-298. PubMed ID: 29518778
[TBL] [Abstract][Full Text] [Related]
5. A Matched Analysis on the Prognostic Impact of Race on Survival Endpoints of Women with Early-Stage Endometrial Cancer.
Feldman A; Chaugle S; Burmeister C; Munkarah A; Elshaikh MA
Gynecol Obstet Invest; 2019; 84(3):283-289. PubMed ID: 30540995
[TBL] [Abstract][Full Text] [Related]
6. The impact of lymphadenectomy on survival endpoints in women with early stage uterine endometrioid carcinoma: A matched analysis.
Ghanem AI; Khan NT; Mahan M; Ibrahim A; Buekers T; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():225-230. PubMed ID: 28068595
[TBL] [Abstract][Full Text] [Related]
7. Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma.
Elshaikh MA; Vance S; Suri JS; Mahan M; Munkarah A
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):351-6. PubMed ID: 24411608
[TBL] [Abstract][Full Text] [Related]
8. Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis.
Isrow D; Burmeister C; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():115-120. PubMed ID: 27838535
[TBL] [Abstract][Full Text] [Related]
9. Is Older Age a Real Adverse Prognostic Factor in Women With Early-Stage Endometrial Carcinoma? A Matched Analysis.
Haley L; Burmeister C; Buekers T; Elshaikh MA
Int J Gynecol Cancer; 2017 Mar; 27(3):479-485. PubMed ID: 28060139
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
[TBL] [Abstract][Full Text] [Related]
11. Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study.
Elshaikh MA; Al-Wahab Z; Mahdi H; Albuquerque K; Mahan M; Kehoe SM; Ali-Fehmi R; Rose PG; Munkarah AR
Gynecol Oncol; 2015 Feb; 136(2):235-9. PubMed ID: 25511158
[TBL] [Abstract][Full Text] [Related]
12. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome.
Gayar OH; Robbins JR; Parikh K; Lu M; Buekers T; Munkarah A; Elshaikh MA
Gynecol Oncol; 2011 Oct; 123(1):71-5. PubMed ID: 21767871
[TBL] [Abstract][Full Text] [Related]
13. Does the Interval Between Hysterectomy and Start of Adjuvant Radiation Treatment Influence Survival in Women With Endometrial Carcinoma?: A National Cancer Database analysis.
Ghanem AI; Modh A; Burmeister C; Mahmoud O; Elshaikh MA
Am J Clin Oncol; 2020 Aug; 43(8):602-606. PubMed ID: 32398405
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma.
Al Khatib S; Bhatnagar A; Elshaikh N; Ghanem AI; Burmeister C; Allo G; Alkamachi B; Paridon A; Elshaikh MA
Am J Clin Oncol; 2023 Oct; 46(10):445-449. PubMed ID: 37525355
[TBL] [Abstract][Full Text] [Related]
15. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
16. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study.
Alagkiozidis I; Grossman A; Tang NZ; Weedon J; Mize B; Salame G; Lee YC; Abulafia O
Int J Surg; 2015 Feb; 14():61-6. PubMed ID: 25576762
[TBL] [Abstract][Full Text] [Related]
17. Obesity and Lymphovascular Invasion in Women with Uterine Endometrioid Carcinoma.
Kamal M; Burmeister C; Zhang Z; Munkarah A; Elshaikh MA
Anticancer Res; 2015 Jul; 35(7):4053-7. PubMed ID: 26124354
[TBL] [Abstract][Full Text] [Related]
18. Histological grade predicts for recurrence in patients with uterine endometrioid carcinoma without myometrial involvement.
Zaki MA; Robbins JR; Fatteh S; Mahan MG; Hanna RK; Elshaikh MA
Anticancer Res; 2012 Sep; 32(9):4061-5. PubMed ID: 22993361
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Adjuvant Management Strategies on Outcomes in Women With Early Stage Uterine Serous Carcinoma.
Cook A; Khalil R; Burmeister C; Dimitrova I; Elshaikh MA
Cureus; 2021 Feb; 13(2):e13505. PubMed ID: 33786214
[TBL] [Abstract][Full Text] [Related]
20. A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma.
Gao Z; Li L; Meng Y
PLoS One; 2016; 11(2):e0148050. PubMed ID: 26828206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
